Psilocybin: research needs caution

Psilocybin, the psychedelic substance in magic mushrooms, has been touted as a treatment for psychiatric disorders, especially depression – but outcomes are questionable, without rigorous research conditions, Johan Lundberg and Guusje Haver of Karolinska Institutet warn.